Pediatric Neurosurgery
Original Paper
Role of Secondary Endoscopic Third Ventriculostomy in Children: Review of an Institutional ExperienceShaikh S. · Deopujari C.E. · Karmarkar V. · Muley K. · Mohanty C.Department of Neurosurgery, Bombay Hospital Institute of Medical Science, Mumbai, India
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Received: February 25, 2019
Accepted: April 27, 2019
Published online: June 03, 2019
Issue release date: July 2019
Number of Print Pages: 8
Number of Figures: 6
Number of Tables: 3
ISSN: 1016-2291 (Print)
eISSN: 1423-0305 (Online)
For additional information: https://www.karger.com/PNE
Abstract
Background: Endoscopic third ventriculostomy (ETV) has become a standard and safe procedure for obstructive hydrocephalus. ETV can also play an important role in children presenting with shunt malfunction with an added advantage of shunt independence. Secondary ETV can be defined as either a redo endoscopic ventriculostomy done after primary ETV stoma closure or that done in cases presenting with shunt malfunction. Objective: The aim of our study was to evaluate the role of secondary ETV in the pediatric age group patients. Methods: This is a retrospective analysis of 36 children (<18 years) who underwent ETV after shunt malfunction and 4 children with ETV done after previous ETV stoma closure from 2004 until 2018. In all patients, the obstructive pattern suggesting aqueduct outflow obstruction was observed on MRI. Patients were followed up for a mean period of 4.25 years. Results: ETV was considered successful if the patient avoided a shunt insertion later on in their life. Considering this definition, a success rate of 72% was observed with secondary ETV for shunt malfunction whereas a success rate of 75% was observed after primary ETV failure without any major side effects in any of the patients. Conclusion: ETV can be considered a primary treatment modality in children with shunt malfunction and has a good success rate in cases presenting with closure of previously performed ETV stoma.
© 2019 S. Karger AG, Basel
Related Articles:
References
- Brockmeyer D, Abtin K, Carey L, Walker ML. Endoscopic third ventriculostomy: an outcome analysis. Pediatr Neurosurg. 1998 May;28(5):236–40.
- Gangemi M, Donati P, Maiuri F, Longatti P, Godano U, Mascari C. Endoscopic third ventriculostomy for hydrocephalus. Minim Invasive Neurosurg. 1999 Sep;42(3):128–32.
- Stein SC, Guo W. Have we made progress in preventing shunt failure? A critical analysis. J Neurosurg Pediatr. 2008 Jan;1(1):40–7.
- Lee SH, Kong DS, Seol HJ, Shin HJ. Endoscopic third ventriculostomy in patients with shunt malfunction. J Korean Neurosurg Soc. 2011 Apr;49(4):217–21.
- Hailong F, Guangfu H, Haibin T, Hong P, Yong C, Weidong L, et al. Endoscopic third ventriculostomy in the management of communicating hydrocephalus: a preliminary study. J Neurosurg. 2008 Nov;109(5):923–30.
- Brichtova E, Chlachula M, Hrbac T, Lipina R. Endoscopic Third Ventriculostomy in Previously Shunted Children. Minim Invasive Surg. 2013;2013:584567.
- Kulkarni AV, Drake JM, Armstrong DC, Dirks PB. Imaging correlates of successful endoscopic third ventriculostomy. J Neurosurg. 2000 Jun;92(6):915–9.
- Stivaros SM, Sinclair D, Bromiley PA, Kim J, Thorne J, Jackson A. Endoscopic third ventriculostomy: predicting outcome with phase-contrast MR imaging. Radiology. 2009 Sep;252(3):825–32.
- Hopf NJ, Grunert P, Fries G, Resch KD, Perneczky A. Endoscopic third ventriculostomy: outcome analysis of 100 consecutive procedures. Neurosurgery. 1999 Apr;44(4):795–804; discussion 804–6.
- Cinalli G, Salazar C, Mallucci C, Yada JZ, Zerah M, Sainte-Rose C. The role of endoscopic third ventriculostomy in the management of shunt malfunction. Neurosurgery. 1998 Dec;43(6):1323–7; discussion 1327–9.
- Siomin V, Weiner H, Wisoff J, Cinalli G, Pierre-Kahn A, Saint-Rose C, et al. Repeat endoscopic third ventriculostomy: is it worth trying? Childs Nerv Syst. 2001 Sep;17(9):551–5.
- O’Brien DF, Javadpour M, Collins DR, Spennato P, Mallucci CL. Endoscopic third ventriculostomy: an outcome analysis of primary cases and procedures performed after ventriculoperitoneal shunt malfunction. J Neurosurg. 2005 Nov;103(5 Suppl):393–400.
- Woodworth G, McGirt MJ, Thomas G, Williams MA, Rigamonti D. Prior CSF shunting increases the risk of endoscopic third ventriculostomy failure in the treatment of obstructive hydrocephalus in adults. Neurol Res. 2007 Jan;29(1):27–31.
- Hader WJ, Walker RL, Myles ST, Hamilton M. Complications of endoscopic third ventriculostomy in previously shunted patients. Neurosurgery. 2008 Jul;63(1 Suppl 1):ONS168–74; discussion ONS174–5.
- Deopujari CE, Karmarkar VS, Shaikh ST, Gadgil US. Developing a dynamic simulator for endoscopic intraventricular surgeries. Childs Nerv Syst. 2019 Apr;35(4):621–7.
- Bilginer B, Oguz KK, Akalan N. Endoscopic third ventriculostomy for malfunction in previously shunted infants. Childs Nerv Syst. 2009 Jun;25(6):683–8.
- Jenkinson MD, Hayhurst C, Al-Jumaily M, Kandasamy J, Clark S, Mallucci CL. The role of endoscopic third ventriculostomy in adult patients with hydrocephalus. J Neurosurg. 2009 May;110(5):861–6.
- Melikian A, Korshunov A. Endoscopic third ventriculostomy in patients with malfunctioning CSF-shunt. World Neurosurg. 2010 Oct-Nov;74(4-5):532–7.
- Baldauf J, Fritsch MJ, Oertel J, Gaab MR, Schröder H. Value of endoscopic third ventriculostomy instead of shunt revision. Minim Invasive Neurosurg. 2010 Aug;53(4):159–63.
- Mahapatra A, Mehr S, Singh D, Tandon M, Ganjoo P, Singh H. Ostomy closure and the role of repeat endoscopic third ventriculostomy (re-ETV) in failed ETV procedures. Neurol India. 2011 Nov-Dec;59(6):867–73.
- Neils DM, Wang H, Lin J. Endoscopic third ventriculostomy for shunt malfunction: what to do with the shunt? Surg Neurol Int. 2013;4(1):3.
- Hellwig D, Giordano M, Kappus C. Redo third ventriculostomy. World Neurosurg. 2013 Feb;79(2 Suppl):S22.e13–20.
- Chan DY, Tsang AC, Ho WW, Cheng KK, Li LF, Tsang FC, et al. Emergency endoscopic third ventriculostomy for blocked shunts? Univariate and multivariate analysis of independent predictors for failure. J Neurosurg. 2018 Nov 1:1–7.
- Spennato P, Ruggiero C, Aliberti F, Nastro A, Mirone G, Cinalli G. Third ventriculostomy in shunt malfunction. World Neurosurg. 2013 Feb;79(2 Suppl):S22.e21–6.
- Marton E, Feletti A, Basaldella L, Longatti P. Endoscopic third ventriculostomy in previously shunted children: a retrospective study. Childs Nerv Syst. 2010 Jul;26(7):937–43.
- Zhao R, Shi W, Yang H, Li H. Endoscopic Third Ventriculostomy Instead of Shunt Revision in Children Younger Than 3 Years of Age. World Neurosurg. 2016 Apr;88:92–6.
- Duru S, Peiro JL, Oria M, Aydin E, Subasi C, Tuncer C, et al. Successful endoscopic third ventriculostomy in children depends on age and etiology of hydrocephalus: outcome analysis in 51 pediatric patients. Childs Nerv Syst. 2018 Aug;34(8):1521–8.
- Siomin V, Cinalli G, Grotenhuis A, Golash A, Oi S, Kothbauer K, et al. Endoscopic third ventriculostomy in patients with cerebrospinal fluid infection and/or hemorrhage. J Neurosurg. 2002 Sep;97(3):519–24.
- Nishiyama K, Mori H, Tanaka R. Changes in cerebrospinal fluid hydrodynamics following endoscopic third ventriculostomy for shunt-dependent noncommunicating hydrocephalus. J Neurosurg. 2003 May;98(5):1027–31.
- Deopujari CE, Karmarkar VS, Shaikh ST. Endoscopic Third Ventriculostomy: success and Failure. J Korean Neurosurg Soc. 2017 May;60(3):306–14.
Article / Publication Details
Received: February 25, 2019
Accepted: April 27, 2019
Published online: June 03, 2019
Issue release date: July 2019
Number of Print Pages: 8
Number of Figures: 6
Number of Tables: 3
ISSN: 1016-2291 (Print)
eISSN: 1423-0305 (Online)
For additional information: https://www.karger.com/PNE
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Get Permission
PubMed ID
